How to Classify Your Medical Device Under EU MDR

If you're bringing a medical device to the European market, classification is the first regulatory decision you'll make — and it determines everything that follows: conformity assessment route, notified body involvement, clinical evidence requirements, and time to market.

This guide walks through the EU MDR classification system practically, so you can determine your device's class and understand what it means for your regulatory strategy.

The EU MDR Classification System

The EU Medical Device Regulation (2017/745) uses a risk-based classification system with four classes:

Class	Risk Level	Examples	Notified Body Required?
Class I	Lowest	Bandages, wheelchairs, stethoscopes	No (self-declaration)*
Class IIa	Low-moderate	Hearing aids, surgical clamps, ultrasound	Yes
Class IIb	Moderate-high	Ventilators, joint replacements, dialysis	Yes
Class III	Highest	Heart valves, implantable defibrillators, drug-device combos	Yes

*Class I devices with measuring function (Im) or sterile (Is) require notified body involvement for those specific aspects.

The 22 Classification Rules

EU MDR Annex VIII contains 22 rules organized by device type. The key principle: if multiple rules apply, the highest class wins.

Non-Invasive Devices (Rules 1–4)

Rule 1: Devices that don't touch the patient or contact only intact skin → Class I
Rule 2: Devices for channeling or storing blood, body fluids, tissues → Class IIa (or IIb if connected to Class IIa+ active device)
Rule 3: Devices that modify biological/chemical composition of blood or body fluids → Class IIb (filtration, centrifugation) or Class III (treatment involving cells)
Rule 4: Devices in contact with injured skin → Class I (mechanical barrier) to Class IIb (chronic wounds, burns)

Invasive Devices (Rules 5–8)

Rule 5: Devices invasive via body orifices (not surgically), transient use → Class I; short-term → Class IIa; long-term → Class IIb
Rule 6: Surgically invasive, transient use → Class IIa (with exceptions pushing to IIb or III)
Rule 7: Surgically invasive, short-term use → Class IIa or IIb (depending on what they do)
Rule 8: Implantable devices and long-term surgically invasive → Class IIb or Class III

Active Devices (Rules 9–13)

Rule 9: Active therapeutic devices for energy exchange → Class IIa (or IIb if potentially hazardous)
Rule 10: Active diagnostic devices → Class IIa (or IIb if directly monitoring vital physiological parameters)
Rule 11: Software → Class IIa default; Class III if intended to influence decisions for diagnosis/treatment of Class III conditions
Rule 12: Active devices delivering medicinal products → Class IIa (or IIb if potentially hazardous manner)
Rule 13: All other active devices → Class I

Special Rules (Rules 14–22)

These cover specific product categories:

Rule 14: Contraceptive/STI prevention devices → Class IIb or Class III (implantable)
Rule 15: Disinfection devices → Class IIa or Class IIb
Rule 16: Non-invasive devices with blood products → Class III
Rule 17: Devices incorporating nanomaterials → up-classified based on exposure
Rule 18: Blood bags → Class IIb
Rule 19: Devices incorporating integral medicinal substance → Class III
Rule 20: Devices incorporating human tissue/cells → Class III
Rule 21: Devices composed of substances introduced into the body → Class III
Rule 22: Active therapeutic devices with integrated diagnostic function → Class III

Common Classification Mistakes

1. Ignoring software rules. Under EU MDR, standalone software (SaMD) is explicitly a medical device. Rule 11 can push diagnostic software to Class III — a major change from the old MDD.

2. Applying only one rule. Multiple rules often apply. A surgical instrument with measuring function hits Rule 6 AND Rule 10. Take the highest class.

3. Confusing intended purpose with capability. Classification follows your stated intended purpose. A general-purpose monitor classified differently than one specifically intended for ICU vital signs monitoring.

4. Overlooking the new rules. Rules 14–22 are new or significantly changed from MDD. Nanomaterials (Rule 17), substance-based devices (Rule 21), and the SaMD rule (Rule 11) catch many manufacturers off guard.

What Happens After Classification?

Your class determines the conformity assessment route:

Class I: Self-declare conformity, prepare technical documentation, register with competent authority
Class IIa: Notified body audits quality management system OR reviews technical documentation
Class IIb/III: Full notified body review of both QMS and technical documentation. Class III requires clinical evidence scrutiny.

The practical difference? Class I can take 3–6 months. Class III can take 18–36 months and cost 10× more.

Classify Your Device Instantly

Not sure which class your device falls into? regMD's free classification tool analyzes your device description against EU MDR rules and 14 other jurisdictions in seconds. No signup required.

For a comprehensive regulatory strategy report covering timelines, costs, and market entry pathways across all 15 markets, get lifetime access for $99.

This article is for informational purposes only and does not constitute regulatory advice. Always verify classifications with the relevant regulatory authority or a qualified regulatory consultant.